Investing.com -- Rhythm Pharmaceuticals (NASDAQ:RYTM) shares rose 11% Friday morning following FDA approval of IMCIVREE (setmelanotide) for patients with acquired hypothalamic obesity. The approval ...
BOSTON - The U.S. Food and Drug Administration approved an expanded indication for Rhythm Pharmaceuticals Inc.’s (NASDAQ:RYTM) Imcivree to treat acquired hypothalamic obesity, the company announced ...
As wearable technologies continue to rapidly develop, the use cases for wearable devices evolve and expand. Artificial intelligence (AI) and machine learning (ML) drive these devices and the latest ...
Background A routine sports evaluation identified constant alternation between a junctional and idioventricular rhythm in a 9-year-old child. During exercise testing, electrography demonstrated that ...
Creates New C-Suite Role to Advance Talent Strategy, Leadership Development, Scalable Operating Rhythms and High-Performance Culture for the Next Phase of Growth NEW YORK, March 16, 2026 /PRNewswire/ ...
FILE PHOTO: A smartphone with a displayed NVIDIA logo is placed on a computer motherboard in this illustration taken March 6, 2023. REUTERS/Dado Ruvic/Illustration/File Photo TAIPEI: Global technology ...
We'll be in your inbox every morning Monday-Saturday with all the day’s top business news, inspiring stories, best advice and exclusive reporting from Entrepreneur.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results